Management of Positive Lyme Screen with Negative IgG and IgM Results
A positive Lyme screen with negative IgG and IgM Western blot results does not indicate active Lyme disease and does not require antibiotic treatment. 1
Understanding Two-Tiered Testing Results
The CDC recommends a two-tiered testing approach for Lyme disease diagnosis:
- First-tier screening test: ELISA or indirect fluorescent antibody test
- Second-tier confirmatory test: Western blot for IgG and IgM antibodies
When interpreting these results:
- A positive first-tier test requires confirmation with Western blot
- For IgM Western blot to be positive: ≥2 of 3 specific bands (21-24,39, and 41 kDa) must be present
- For IgG Western blot to be positive: ≥5 of 10 specific bands must be present 2
Clinical Decision Making
In this case:
- The screening test is positive
- Both IgG and IgM Western blots are negative
- This pattern represents a false-positive screening test 1
Key Points:
- Isolated positive screening tests without Western blot confirmation have poor specificity
- Cross-reactions with other bacterial antigens are common 3
- Overinterpreting a small number of antibody bands or a positive screening test alone leads to reduced specificity and potential misdiagnosis 2
Recommended Approach
Do not initiate antibiotic therapy based on a positive screening test with negative Western blot results 1
Reassess clinical presentation:
- If erythema migrans rash is present in an endemic area, treat empirically regardless of serology 1
- If no characteristic symptoms are present, consider alternative diagnoses
Consider follow-up testing only if:
- Symptoms consistent with early Lyme disease develop
- There is a known recent tick exposure with symptoms
- Testing was performed very early (within first 1-2 weeks of infection) 2
Common Pitfalls to Avoid
Overtreatment: Administering antibiotics based solely on positive screening tests leads to unnecessary antibiotic use and potential side effects 1
Misinterpretation: Positive screening with negative confirmatory testing is not diagnostic of Lyme disease 2, 3
Repeated testing: Without clinical changes, repeated testing increases the likelihood of false-positive results 1
Extended antibiotic courses: Not supported by evidence and may lead to adverse effects 1
Special Considerations
- If clinical suspicion remains high despite negative serology, consider whether:
- Testing was performed too early in the disease course
- The patient has an erythema migrans rash in an endemic area (which allows clinical diagnosis)
- Alternative diagnoses might explain the symptoms 1
Remember that serology as a single diagnostic tool has limited value and should only be used to support clinically suspected cases 3. The presence of nonspecific symptoms with a positive screening test but negative Western blot does not constitute evidence of active Lyme infection.